Literature DB >> 10446376

Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.

Z Kovarik1, Z Radić, B Grgas, M Skrinjarić-Spoljar, E Reiner, V Simeon-Rudolf.   

Abstract

In order to identify amino acids involved in the interaction of acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (BChE; EC 3.1.1.8) with carbamates, the time course of inhibition of the recombinant mouse enzymes BChE wild-type (w.t.), AChE w.t. and of 11 site-directed AChE mutants by Ro 02-0683 and bambuterol was studied. In addition, the reversible inhibition of cholinesterases by terbutaline, the leaving group of bambuterol, was studied. The bimolecular rate constant of AChE w.t. inhibition was 6.8 times smaller by Ro 02-0683 and 16000 times smaller by bambuterol than that of BChE w.t. The two carbamates were equipotent BChE inhibitors. Replacement of tyrosine-337 in AChE with alanine (resembling the choline binding site of BChE) resulted in 630 times faster inhibition by bambuterol. The same replacement decreased the inhibition by Ro 02-0683 ten times. The difference in size of the choline binding site in the two w.t. enzymes appeared critical for the selectivity of bambuterol and terbutaline binding. Removal of the charge with the mutation D74N caused a reduction in the reaction rate constants for Ro 02-0683 and bambuterol. Substitution of tyrosine-124 with glutamine in the AChE peripheral site significantly increased the inhibition rate for both carbamates. Substitution of phenylalanine-297 with alanine in the AChE acyl pocket decreased the inhibition rate by Ro 02-0683. Computational docking of carbamates provided plausible orientations of the inhibitors inside the active site gorge of mouse AChE and human BChE, thus substantiating involvement of amino acid residues in the enzyme active sites critical for the carbamate binding as derived from kinetic studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446376     DOI: 10.1016/s0167-4838(99)00124-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Enzymatic detoxification of organophosphorus pesticides and related toxicants.

Authors:  Karla Alejo-González; Erik Hanson-Viana; Rafael Vazquez-Duhalt
Journal:  J Pestic Sci       Date:  2018-02-28       Impact factor: 1.519

2.  Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.

Authors:  Zrinka Kovarik; Zoran Radić; Harvey A Berman; Vera Simeon-Rudolf; Elsa Reiner; Palmer Taylor
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

3.  Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Authors:  Chang-Guo Zhan; Fang Zheng; Donald W Landry
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

4.  A wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulations.

Authors:  Brian J Bennion; Sebnem G Essiz; Edmond Y Lau; Jean-Luc Fattebert; Aiyana Emigh; Felice C Lightstone
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Reduced vagal control of the heart in high-fat diet mice: a potential role of increased butyrylcholinesterase.

Authors:  Sigurd Hartnett; Hongbo Gao; Sabrina Schnack; Yifan Li
Journal:  Physiol Rep       Date:  2015-11

6.  Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.

Authors:  Anita Bosak; Anamarija Knežević; Ivana Gazić Smilović; Goran Šinko; Zrinka Kovarik
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

7.  Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase.

Authors:  Tena Čadež; Dora Kolić; Goran Šinko; Zrinka Kovarik
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

8.  Identification of Compounds for Butyrylcholinesterase Inhibition.

Authors:  Shuaizhang Li; Andrew J Li; Jameson Travers; Tuan Xu; Srilatha Sakamuru; Carleen Klumpp-Thomas; Ruili Huang; Menghang Xia
Journal:  SLAS Discov       Date:  2021-07-16       Impact factor: 3.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.